-
CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Ce
2026-05-26
The CFDA SE Cell Tracer Kit addresses the need for robust, long-term covalent fluorescent labeling in cell proliferation and lineage tracing workflows. It is best suited for applications requiring durable, persistent tracking of cell populations, and should not be used for workflows demanding reversible or short-term cell labeling.
-
Blocking Extracellular Vesicle Release in Triple-Negative Br
2026-05-25
McNamee et al. provide a systematic evaluation of inhibitors targeting extracellular vesicle (EV) release in triple-negative breast cancer (TNBC), revealing that near-complete EV suppression is necessary to curtail the transmission of aggressive cancer traits. This work establishes foundational protocols for EV modulation and informs future strategies in cancer cell communication research.
-
Prednisone as a Translational Lever: Mechanism, Modeling, an
2026-05-25
This thought-leadership article unpacks the mechanistic depth and translational strategy behind Prednisone, a synthetic corticosteroid, as an advanced research tool. By bridging molecular mechanisms with bench-to-bedside assay design and integrating comparative perspectives from botanical modeling, we provide actionable guidance for researchers navigating immunology, neurodegeneration, and model optimization. This article builds on—but distinctly advances beyond—conventional product listings by contextualizing APExBIO’s Prednisone within current challenges and opportunities in translational research.
-
ML385: A Selective NRF2 Inhibitor for Cutting-Edge Research
2026-05-24
ML385 empowers researchers to dissect NRF2-mediated antioxidant and resistance mechanisms with high specificity, driving breakthroughs in cancer, oxidative stress, and ferroptosis research. Recent in vivo studies validate its translational potential and provide actionable parameters for robust experimental design.
-
Pregnenolone Carbonitrile: Optimizing Rodent PXR Assays
2026-05-23
Pregnenolone Carbonitrile enables precise control of rodent PXR activation for robust CYP3A induction and antifibrotic studies. Recent advances show gut microbiota is pivotal in mediating its hepatoprotective effects, reshaping experimental workflows for liver injury and xenobiotic metabolism research.
-
CHIR-99021 (CT99021): Optimizing Stem Cell and Differentiati
2026-05-22
CHIR-99021 (CT99021) empowers researchers to reliably maintain pluripotency, direct lineage specification, and dissect Wnt/β-catenin and TGF-β/Nodal signaling with unparalleled selectivity. This article translates bench research and recent breakthroughs into actionable steps, unlocking advanced stem cell and disease modeling applications.
-
Vancomycin Hydrochloride in Advanced Antibiotic Resistance A
2026-05-22
Vancomycin hydrochloride empowers precise, reproducible workflows for studying Gram-positive bacterial inhibition and antibiotic resistance profiling. This article connects cutting-edge animal model research with practical laboratory protocols, spotlighting real-world troubleshooting strategies for robust outcomes.
-
Bifendate (DDB): Unraveling Dose-Dependent Lipid and Hepatic
2026-05-21
Explore how bifendate (DDB) acts as a hepatoprotection agent with nuanced dose-dependent impacts on lipid metabolism and autophagy. This in-depth review clarifies mechanistic findings and practical protocols, revealing applications and limitations overlooked elsewhere.
-
Pharmacokinetics of Corydalis Alkaloids in MASH: Mechanisms
2026-05-21
This study systematically analyzes the pharmacokinetic variability and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH). The findings reveal how disease state and transporter/enzyme expression shape systemic exposure and liver accumulation of key alkaloids, informing rational dosing strategies for MASLD/MASH therapies.
-
Hoechst 33258: Optimizing Bis-Benzimide DNA Staining Workflo
2026-05-20
Hoechst 33258 is a gold-standard bis-benzimide DNA stain, enabling high-fidelity DNA visualization in live and fixed cells—even under challenging tumor microenvironment conditions. This guide covers practical protocols, advanced cell cycle and tumor pH studies, and troubleshooting tips, drawing on the latest chemo-immunotherapy innovations.
-
Naloxone Hydrochloride: Redefining Opioid Antagonism in Tran
2026-05-20
Naloxone hydrochloride, widely recognized as a life-saving opioid overdose reversal agent, has emerged as an essential probe for translational researchers seeking to unravel the complexities of opioid receptor signaling, neural stem cell modulation, and immune function. This thought-leadership article blends mechanistic insight with practical guidance, positioning APExBIO’s high-purity Naloxone (hydrochloride) as a cornerstone reagent for preclinical and translational workflows. By exploring advanced applications, competitive landscape, and future directions, this piece provides actionable intelligence and strategic context for the next generation of addiction, neuroregeneration, and immune modulation studies.
-
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui
2026-05-19
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe (SKU B8804) addresses the need for robust, selective plasma membrane labeling in both live and fixed cell workflows, including neuronal tracing and migration analysis. It should not be used for aqueous staining protocols or for exclusive cytoplasmic or organelle labeling, as its performance and specificity depend on membrane compatibility and correct solvent handling.
-
LY2109761: Precision TGF-β Receptor I/II Dual Inhibition in
2026-05-19
LY2109761 empowers researchers to dissect TGF-β signaling with high selectivity, enabling robust modeling of cancer, fibrosis, and radiotherapy response. This guide details actionable workflows, troubleshooting, and unique insights from recent studies to ensure reproducible, high-impact results.
-
Anti Reverse Cap Analog (ARCA): Enhancing mRNA Translation E
2026-05-18
Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, is a chemically engineered mRNA cap analog that ensures orientation-specific capping, nearly doubling translational efficiency in vitro. Its precision design supports high-yield mRNA synthesis for therapeutics and research applications. APExBIO’s ARCA (B8175) demonstrates robust performance for synthetic mRNA workflows.
-
Mitoxantrone HCl: DNA Topoisomerase II Inhibitor in Research
2026-05-18
Mitoxantrone HCl is a potent DNA topoisomerase II inhibitor widely used in molecular biology and oncology research. It induces DNA double-strand breaks and modulates immune cell activity, supporting studies in cancer, apoptosis, and immune modulation. Recent evidence highlights novel mechanisms involving nuclear receptor targeting.
493 records 13/33 page Previous Next First page 上5页 1112131415 下5页 Last page